EP2964237A4 - Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire - Google Patents

Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire

Info

Publication number
EP2964237A4
EP2964237A4 EP14751247.9A EP14751247A EP2964237A4 EP 2964237 A4 EP2964237 A4 EP 2964237A4 EP 14751247 A EP14751247 A EP 14751247A EP 2964237 A4 EP2964237 A4 EP 2964237A4
Authority
EP
European Patent Office
Prior art keywords
population
maintaining
subject
methods
need
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14751247.9A
Other languages
German (de)
English (en)
Other versions
EP2964237A2 (fr
Inventor
Patrick Ching-Ho Hsieh
Chia-Yun Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Cheng Kung University NCKU
DCB USA LLC
Original Assignee
National Cheng Kung University NCKU
DCB USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Cheng Kung University NCKU, DCB USA LLC filed Critical National Cheng Kung University NCKU
Publication of EP2964237A2 publication Critical patent/EP2964237A2/fr
Publication of EP2964237A4 publication Critical patent/EP2964237A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
EP14751247.9A 2013-02-15 2014-02-14 Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire Withdrawn EP2964237A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361765075P 2013-02-15 2013-02-15
PCT/US2014/016477 WO2014127232A2 (fr) 2013-02-15 2014-02-14 Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire

Publications (2)

Publication Number Publication Date
EP2964237A2 EP2964237A2 (fr) 2016-01-13
EP2964237A4 true EP2964237A4 (fr) 2016-11-30

Family

ID=51354685

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14751247.9A Withdrawn EP2964237A4 (fr) 2013-02-15 2014-02-14 Méthodes destinées à maintenir une population de cellules thérapeutiques sur le site de traitement chez un sujet ayant besoin d'une thérapie cellulaire

Country Status (3)

Country Link
EP (1) EP2964237A4 (fr)
CN (1) CN105228632A (fr)
WO (1) WO2014127232A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2978109A1 (fr) * 2015-03-31 2016-10-06 The University Of North Carolina At Chapel Hill Vehicules d'apport pour cellules souches et leurs utilisations
US20170151416A1 (en) * 2015-12-01 2017-06-01 Invivo Therapeutics Corporation Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
US10676634B2 (en) * 2018-09-05 2020-06-09 Swimc Llc Modified latent crosslinker in polymeric systems
IT201800020722A1 (it) * 2018-12-21 2020-06-21 Assunta Borzacchiello Biomateriale e suo utilizzo nel trattamento di patologie polmonari

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
WO2004104166A2 (fr) * 2003-05-07 2004-12-02 La Jolla Institute For Molecular Medicine Methodes permettant de faciliter la recuperation de fonctions de cellules souches endogenes, implantees ou transplantees au moyen d'un acide hyaluronique de poids moleculaire eleve
WO2007070546A2 (fr) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Implant méniscal de dérivés d'acide hyaluronique destiné au traitement de défauts méniscaux
US20090252700A1 (en) * 2003-01-10 2009-10-08 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
KR20130009651A (ko) * 2011-07-13 2013-01-23 (주)차바이오앤디오스텍 콜라겐, 히알루론산 유도체 및 포유류의 탯줄 유래 줄기세포를 포함하는 연골세포치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109659A2 (fr) * 2007-03-06 2008-09-12 University Of North Carolina At Chapel Hill Complexe d'hyaluronanes, autres composants de matrice, hormones et facteurs de croissance pour maintenance, expansion et/ou différenciation de cellules
WO2010127254A2 (fr) * 2009-04-30 2010-11-04 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Matériau élastomère, biodégradable, thermosensible et utilisations de celui-ci
WO2011072399A1 (fr) * 2009-12-18 2011-06-23 The Governing Council Of The University Of Toronto Composition polymère injectable utilisée comme véhicule pour l'administration de cellules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
US20090252700A1 (en) * 2003-01-10 2009-10-08 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2004104166A2 (fr) * 2003-05-07 2004-12-02 La Jolla Institute For Molecular Medicine Methodes permettant de faciliter la recuperation de fonctions de cellules souches endogenes, implantees ou transplantees au moyen d'un acide hyaluronique de poids moleculaire eleve
WO2007070546A2 (fr) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Implant méniscal de dérivés d'acide hyaluronique destiné au traitement de défauts méniscaux
KR20130009651A (ko) * 2011-07-13 2013-01-23 (주)차바이오앤디오스텍 콜라겐, 히알루론산 유도체 및 포유류의 탯줄 유래 줄기세포를 포함하는 연골세포치료제

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DREW KURAITIS ET AL: "Exploiting extracellular matrix-stem cell interactions: A review of natural materials for therapeutic muscle regeneration", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 33, no. 2, 28 September 2011 (2011-09-28), pages 428 - 443, XP028101922, ISSN: 0142-9612, [retrieved on 20111001], DOI: 10.1016/J.BIOMATERIALS.2011.09.078 *
GAETANO LA MANNA ET AL: "Mesenchymal Stem Cells in Renal Function Recovery After Acute Kidney Injury: Use of a Differentiating Agent in a Rat Model", CELL TRANSPLANTATION, vol. 20, no. 8, 19 November 2010 (2010-11-19), US, pages 1193 - 1208, XP055309355, ISSN: 0963-6897, DOI: 10.3727/096368910X543394 *
GLENN D. PRESTWICH ET AL: "The translational imperative: Making cell therapy simple and effective", ACTA BIOMATERIALIA, vol. 8, no. 12, 7 July 2012 (2012-07-07), NL, pages 4200 - 4207, XP055309337, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2012.06.043 *
GLENN D. PRESTWICH: "Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine", JOURNAL OF CONTROLLED RELEASE, vol. 155, no. 2, 1 October 2011 (2011-10-01), pages 193 - 199, XP055011774, ISSN: 0168-3659, DOI: 10.1016/j.jconrel.2011.04.007 *

Also Published As

Publication number Publication date
WO2014127232A3 (fr) 2015-10-29
WO2014127232A2 (fr) 2014-08-21
CN105228632A (zh) 2016-01-06
EP2964237A2 (fr) 2016-01-13

Similar Documents

Publication Publication Date Title
CY2019008I1 (el) Χρηση τροποποιημενων απο χιμαιρικο αντιγονικο υποδοχεα τ κυτταρων στη θεραπευτικη αγωγη καρκινου
CY2023010I1 (el) Προφαρμακα καρβιντοπας και l-ντοπας και η χρηση τους στην αγωγη της νοσου parkinson
IL239923A0 (en) Solid solution compositions and use in cardiovascular disease
IL237592B (en) Methods of expanding and assessing b cells and using expanded b cells to treat disease
MX380943B (es) Compuestos terapeuticamente activos y sus metodos de uso.
BR112015022854A2 (pt) pró-farmacos de fumaratos e uso do mesmo no tratamento de várias doenças
EP3071280A4 (fr) Cathéter de traitement comprenant l'administration d'une énergie thérapeutique
EA201500314A1 (ru) Лекарственные формы энзалутамида
PL2780036T3 (pl) Kompozycje nanocząstek do generowania regulatorowych komórek t i leczenie chorób autoimmunologicznych i innych przewlekłych stanów zapalnych
EP2770899A4 (fr) Imagerie tissulaire et cellulaire
IL232256A0 (en) Novel purine derivatives and their use in the treatment of disease
EP2713732A4 (fr) Pirfénidone et traitement antifibrotique chez des patients sélectionnés
MA39960A (fr) Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer
IL234101B (en) Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
HUE054783T2 (hu) Pridopidin Huntington-kór kezelésében
DK3730136T3 (da) Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom
MA52542A (fr) Thérapie cellulaire adoptive
HUE054196T2 (hu) Terápiás szerek nemkívánatos sejtproliferációhoz kapcsolódó betegségek kezelésére
DK3419673T3 (da) Genterapi til behandling af sygdom i nethindens tapceller
EP2739244A4 (fr) Systèmes, méthodes et implants dans le traitement du prolapsus ou de l'incontinence
EP2707052A4 (fr) Appareil à canule et systèmes d'assistance ventriculaire utilisant l'appareil à canule
PL2613801T3 (pl) Zastosowanie komórek T pamięci centralnych przeciwko obcym antygenom do leczenia białaczki/chłoniaka
EP2947141A4 (fr) Micro-organismes produisant de l'acide docosahexaénoïque et leur utilisation
DK3363437T3 (da) Aminoindanforbindelser og anvendelse deraf i behandling af smerte
EP3067441A4 (fr) Bain électrolytique à membrane d'échange d'ions et corps élastique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150828

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20161103

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/34 20060101ALI20161025BHEP

Ipc: A61K 35/51 20150101ALI20161025BHEP

Ipc: A61K 35/36 20060101ALI20161025BHEP

Ipc: A61K 35/12 20060101AFI20161025BHEP

Ipc: A61K 35/35 20150101ALI20161025BHEP

Ipc: A61K 35/32 20060101ALI20161025BHEP

Ipc: A61K 35/50 20150101ALI20161025BHEP

Ipc: A61K 35/28 20060101ALI20161025BHEP

Ipc: A61K 31/728 20060101ALI20161025BHEP

Ipc: A61K 35/545 20150101ALI20161025BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170603